These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32736959)

  • 1. The impact of COVID-19 restrictions on needle and syringe programme provision and coverage in England.
    Whitfield M; Reed H; Webster J; Hope V
    Int J Drug Policy; 2020 Sep; 83():102851. PubMed ID: 32736959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-series analysis of presentations to four syringe dispensing machines and a needle and syringe programme during COVID-19 lockdowns in Melbourne, Australia.
    O'Keefe D; Livingston M; Cossar RD; Kerr P; Jacka D; Dietze P
    Harm Reduct J; 2022 Sep; 19(1):101. PubMed ID: 36071500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the cost-effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs.
    Sweeney S; Ward Z; Platt L; Guinness L; Hickman M; Hope V; Maher L; Iversen J; Hutchinson SJ; Smith J; Ayres R; Hainey I; Vickerman P
    Addiction; 2019 Mar; 114(3):560-570. PubMed ID: 30674091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "No-one just does drugs during business hours!": evaluation of a 24/7 primary needle and syringe program in St Kilda, Australia.
    Walker S; Curtis M; Kirwan A; Thatcher R; Dietze P
    Harm Reduct J; 2024 Feb; 21(1):51. PubMed ID: 38402389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia.
    Aceijas C; Hickman M; Donoghoe MC; Burrows D; Stuikyte R
    Addiction; 2007 Aug; 102(8):1244-50. PubMed ID: 17565564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary distribution of injecting equipment obtained from needle and syringe programmes by people injecting image and performance enhancing drugs: England and Wales, 2012-15.
    Glass R; Hope VD; Njoroge J; Edmundson C; Smith J; McVeigh J; Parry J; Desai M
    Drug Alcohol Depend; 2019 Feb; 195():40-44. PubMed ID: 30580202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of time of drug use according to needle and syringe program operating hours in Melbourne, Australia: Effects on individual-level needle and syringe coverage.
    O'Keefe D; Aitken C; Scott N; Dietze P
    Drug Alcohol Depend; 2018 Oct; 191():259-265. PubMed ID: 30153607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic.
    Lindqvist K; Wallmofeldt C; Holmén E; Hammarberg A; Kåberg M
    Harm Reduct J; 2021 May; 18(1):52. PubMed ID: 33971892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual-level syringe coverage among Needle and Syringe Program attendees in Australia.
    Iversen J; Topp L; Wand H; Maher L
    Drug Alcohol Depend; 2012 May; 122(3):195-200. PubMed ID: 22071120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.
    Palmateer N; Kimber J; Hickman M; Hutchinson S; Rhodes T; Goldberg D
    Addiction; 2010 May; 105(5):844-59. PubMed ID: 20219055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceived discrimination and injecting risk among people who inject drugs attending Needle and Syringe Programmes in Sydney, Australia.
    Wilson H; Brener L; Mao L; Treloar C
    Drug Alcohol Depend; 2014 Nov; 144():274-8. PubMed ID: 25236889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Needle and syringe distribution trends in Western Australia, 1990 to 2009.
    Lilley G; Mak DB; Fredericks T
    Drug Alcohol Rev; 2013 May; 32(3):320-7. PubMed ID: 22963615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syringe Stockpiling by Persons Who Inject Drugs: An Evaluation of Current Measures for Needle and Syringe Program Coverage.
    McCormack AR; Aitken CK; Burns LA; Cogger S; Dietze PM
    Am J Epidemiol; 2016 May; 183(9):852-60. PubMed ID: 27049004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of pharmacy-based needle/syringe exchange programme for people who inject drugs: a systematic review and meta-analysis.
    Sawangjit R; Khan TM; Chaiyakunapruk N
    Addiction; 2017 Feb; 112(2):236-247. PubMed ID: 27566970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is point of access to needles and syringes related to needle sharing? Comparing data collected from pharmacies and needle and syringe programs in south-east Sydney.
    Bryant J; Topp L; Hopwood M; Iversen J; Treloar C; Maher L
    Drug Alcohol Rev; 2010 Jul; 29(4):364-70. PubMed ID: 20636651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How does the use of multiple needles/syringes per injecting episode impact on the measurement of individual level needle and syringe program coverage?
    O'Keefe D; McCormack A; Cogger S; Aitken C; Burns L; Bruno R; Stafford J; Butler K; Breen C; Dietze P
    Int J Drug Policy; 2017 Aug; 46():99-106. PubMed ID: 28667880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geo-spatial analysis of individual-level needle and syringe coverage in Melbourne, Australia.
    O'Keefe D; Wilkinson A; Aitken C; Dietze P
    PLoS One; 2018; 13(12):e0209280. PubMed ID: 30550588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are there differences in individual-level needle and syringe coverage across Australian jurisdictions related to program policy? A preliminary analysis.
    Hill P; O'Keefe D; Dietze PM
    Drug Alcohol Rev; 2018 Jul; 37(5):653-657. PubMed ID: 29851167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal analysis of change in individual-level needle and syringe coverage amongst a cohort of people who inject drugs in Melbourne, Australia.
    O'Keefe D; Scott N; Aitken C; Dietze P
    Drug Alcohol Depend; 2017 Jul; 176():7-13. PubMed ID: 28463684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond equipment distribution in Needle and Syringe Programmes: an exploratory analysis of blood-borne virus risk and other measures of client need.
    Treloar C; Mao L; Wilson H
    Harm Reduct J; 2016 May; 13(1):18. PubMed ID: 27246345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.